One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

ZUG, Switzerland I 13, 2024 I MoonLake Immunotherapeutics (MoonLake; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

A recent cohort study suggests physical activity may improve psoriasis severity and cardiovascular health, showing reduced PASI scores and better BP.

Discover a recent study from 12 hospitals across China that has shed new light on personalised care for plaque psoriasis.

This included data from the phase 3 Opportuniti study (ClinicalTrials.gov Identifier: NCT04785326), which compared the biosimilar to Stelara in patients with moderate to severe chronic plaque ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Psoriasis is a chronic autoimmune skin condition that causes patches of thick, red, scaly skin. Usually, the elbows, knees, ...

Most extensive LEO Pharma program to date at the European Academy of Dermatology and Venereology (EADV) congress featured an ...